- 全部删除
您的购物车当前为空
Romosozumab (AMG-785) 是人源化可结合并抑制硬化蛋白的单克隆抗体,可增加骨形成,减少骨吸收。Romosozumab 可用于研究绝经后骨质疏松症。

为众多的药物研发团队赋能,
让新药发现更简单!
Romosozumab (AMG-785) 是人源化可结合并抑制硬化蛋白的单克隆抗体,可增加骨形成,减少骨吸收。Romosozumab 可用于研究绝经后骨质疏松症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,324 | In stock | |
| 5 mg | ¥ 5,810 | In stock | |
| 10 mg | ¥ 8,715 | In stock | |
| 25 mg | ¥ 14,815 | In stock | |
| 50 mg | ¥ 22,220 | In stock |
Romosozumab 相关产品
| 产品描述 | Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis. |
| 体内活性 | Romosozumab(30 mg/kg,每周两次,持续10周)可促使食蟹猴的骨小梁杆状结构转变为板状结构。[1] |
| 别名 | 罗莫单抗, CDP-7851, CDP7851, AMG-785, AMG785 |
| CAS No. | 909395-70-6 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容